2009
DOI: 10.1016/j.jbiotec.2009.08.010
|View full text |Cite
|
Sign up to set email alerts
|

In silico modeling and metabolome analysis of long-stored erythrocytes to improve blood storage methods

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
61
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(63 citation statements)
references
References 50 publications
2
61
0
Order By: Relevance
“…Diphosphoglycerate (DPG) levels followed trends already reported in literature, 11,20 with early moderate accumulation up to day 7 and then a constant decrease until day 21 and onwards, at which point the concentrations were as low as 0.05±0.01% of the original day 0 values.…”
Section: Time-course Metabolomicssupporting
confidence: 67%
See 1 more Smart Citation
“…Diphosphoglycerate (DPG) levels followed trends already reported in literature, 11,20 with early moderate accumulation up to day 7 and then a constant decrease until day 21 and onwards, at which point the concentrations were as low as 0.05±0.01% of the original day 0 values.…”
Section: Time-course Metabolomicssupporting
confidence: 67%
“…Lactate, which is a frequently measured parameter in metabolic analyses of RBC, 11,20 , constantly accumulated as storage progressed, reaching a final 20.39±0.9 fold increase in comparison to day 0 control levels.…”
Section: Time-course Metabolomicsmentioning
confidence: 94%
“…In a previous study, Nishino et al developed a mathematical model for erythrocytes and used it to predict metabolic changes occurring during their long-term storage. In silico simulations reproduced the reported time-courses of ATP and 2.3-DPG during storage and these predictions were validated by comparison with metabolomics data [21].…”
Section: Systems Biology Of Stored Blood Cellsmentioning
confidence: 58%
“…There are very few reports providing comprehensive measurements of metabolites present in the RBCs 17 and no reports on global metabolites changes associated with SCD. The aim of this study was to develop a simple and comprehensive strategy for metabolite extraction and metabolome analysis of purified human RBCs from normal person and sickle cell-affected patients and also to determine pathways that might be of interest to prevent vaso-occlusion and to monitor the effects of new drugs on SCD.…”
Section: Introductionmentioning
confidence: 99%